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We thank Gonzalez-Juanatey and colleagues [1] for their
response to our editorial [2]. They refer to their interesting
recent work [3], reporting that carotid intima-media thickness
(IMT) is associated with future cardiovascular events in
patients with rheumatoid arthritis (RA). Although this is poten-
tially important, because this was a longitudinal observational
study conducted over a 5-year period of follow up, there are
some shortcomings that may be of significance. The cohort
(47 patients) and number of events (8) were small, allowing
for statistical error. Patients who developed cardiovascular
events not only had significantly higher carotid IMT but were
also significantly older than those who did not; greater age is
associated with both carotid IMT and cardiovascular event
risk [4]. This, together with other possible confounders, might
have had a major impact on the results. The degree of sys-
temic inflammation in patients when carotid IMT was asses-
sed and during follow up was not presented. One of those
patients who developed a cardiovascular event appears to
have been an extreme outlier with a very high carotid IMT. Did
that patient have a particularly high inflammatory load at the
time of assessment?
Carotid IMT has been shown to reduce in response to anti-
tumour necrosis factor-α treatment in patients with RA [5].
This raises the question as to whether, in states characterized
by high-grade inflammation such as RA, carotid IMT reflects
current inflammatory load rather than more permanent,
structural vessel changes. If the former is true, then a ‘high’
carotid IMT measured during a ‘flare’ of disease activity may
not be a good predictor of future cardiovascular events. This
question has not been addressed in the study conducted by
Gonzalez-Juanatey and colleagues [3]. Their study lends
credence to the continuing use of surrogates of athero-
sclerotic cardiovascular disease in patients with RA. How-
ever, we believe that the short-term and long-term interplay
between degrees of systemic inflammation and surrogates
that are thought to reflect functional or structural vessel
changes, as well as the overall metabolic state of the
individual patient, requires more investigation in longitudinal
studies designed specifically for this purpose.
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